author-photo

Rafal Wierzbicki

Durham University

35

Papers

2598

Citations

Citation Trend

Filter By

Papers (27) Sort By

Journal Conference Others

A Randomized Phase II study of Reolysin in Patients with Previously Treated Advanced or Metatstatic Non Small Cell Lung Cancer (NSCLC) receiving Standard Salvage Chemotherapy – Canadian Cancer Trials Group IND 211.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
A randomized trial of first-line irinotecan/fluoropymidine combinations with or without celecoxib in metastatic colorectal cancer (BICC-C)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (48)
A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer

2015 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (24)
1312PTHE RELATIONSHIP BETWEEN EGFR AND KRAS MUTATION STATUS AND OVERALL SURVIVAL (OS) IN THE NCIC CTG BR.26 RANDOMIZED TRIAL OF DACOMITINIB (D) VERSUS PLACEBO (P) IN PATIENTS WITH PREVIOUSLY TREATED NON SMALL CELL LUNG CANCER (NSCLC)

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

2014 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (95)
Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL)

2013 Supportive Care in Cancer
Show All
- Source
- Cite
- Save
Citations (26)
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer

2012 Default journal
Show All
- Source
- Cite
- Save
Citations (0)
Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Phase III Trial

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (188)
Erlotinib de primera línea seguido de quimioterapia con cisplatino‑gemcitabina de segunda línea en el cáncer de pulmón no microcítico avanzado: ensayo aleatorizado

2012
Show All
- Source
- Cite
- Save
Citations (0)
Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer

2012 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (18)